Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The HIV-1 envelope (Env) spike is a trimer of gp120/gp41 heterodimers that mediates viral entry. Binding to CD4 on the host cell membrane is the first essential step for infection but disrupts the native antigenic state of Env, posing a key obstacle to vaccine development. We locked the HIV-1 Env trimer in a pre-fusion configuration, resulting in impaired CD4 binding and enhanced binding to broadly neutralizing antibodies. This design was achieved via structure-guided introduction of neo-disulfide bonds bridging the gp120 inner and outer domains and was successfully applied to soluble trimers and native gp160 from different HIV-1 clades. Crystallization illustrated the structural basis for CD4-binding impairment. Immunization of rabbits with locked trimers from two different clades elicited neutralizing antibodies against tier-2 viruses with a repaired glycan shield regardless of treatment with a functional CD4 mimic. Thus, interdomain stabilization provides a widely applicable template for the design of Env-based HIV-1 vaccines.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007033PMC
http://dx.doi.org/10.1016/j.chom.2018.05.002DOI Listing

Publication Analysis

Top Keywords

interdomain stabilization
8
cd4 binding
8
hiv-1 envelope
8
neutralizing antibodies
8
hiv-1
5
stabilization impairs
4
cd4
4
impairs cd4
4
binding
4
binding improves
4

Similar Publications

The E76K mutation in protein tyrosine phosphatase (PTP) SHP2 is a recurrent driver of developmental disorders and cancers, yet the mechanism by which this single-site substitution promotes persistent activation remains elusive. Here, we combine path-based conformational sampling, unbiased molecular dynamics (MD) simulations, Markov state models (MSMs), and neural relational inference (NRI) to elucidate how E76K reshapes the activation landscape and regulatory architecture of SHP2. Using a minimum-action trajectory derived from experimentally determined closed and open structures, we generated representative transition intermediates to guide the unbiased MD simulations.

View Article and Find Full Text PDF

The DExD/H-box RNA helicase Prp22 catalyzes messenger RNA (mRNA) release from the spliceosome, and has also been implicated in proofreading the 3' splice site (3'SS), preventing exon ligation of mutant pre-mRNAs through an ATP-dependent mechanism. However, here we reveal an unexpected role for Prp22 in promoting exon ligation of both wild-type and mutant pre-mRNAs by stabilizing Slu7's association with the spliceosome prior to exon ligation. Notably, ATP binding, rather than hydrolysis, by Prp22 inhibits exon ligation of 3'SS mutant pre-mRNA.

View Article and Find Full Text PDF

Two different domain swapped dimer structures were revealed by crystal structure of EPIC1 from Phytophthora nicotianae.

Biochem Biophys Res Commun

August 2025

College of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, 06974, Republic of Korea. Electronic address:

Cysteine protease inhibitors such as cystatins are crucial regulators of proteolytic activity involved in immunity, host-pathogen interactions, and cellular homeostasis. EPIC1, a cystatin-like inhibitor secreted by plant pathogen, such as Phytophthora nicotianae, suppresses host immunity by targeting papain-like cysteine proteases. Here, we report the high-resolution crystal structure of EPIC1, revealing a domain-swapped dimer architecture in which structural elements are exchanged between monomers.

View Article and Find Full Text PDF

Understanding the structural determinants of antibody stability and aggregation is essential for therapeutic development. In this study, we investigated the unfolding and refolding behavior of bevacizumab under denaturing conditions using dynamic light scattering (DLS), circular dichroism (CD), and hydrogen-deuterium exchange mass spectrometry (HDX-MS). Unfolding was induced by incubating the antibody in 4 M guanidine hydrochloride (Gnd-HCl), followed by refolding through dilution with 1 M Gnd-HCl.

View Article and Find Full Text PDF

Trikafta modulators can correct the thermal and gating defects of the most common cystic fibrosis mutant F508del of the human cystic fibrosis transmembrane conductance regulator (hCFTR). While folding correctors VX-445 and VX-809 are sufficient to restore the Mg/ATP-dependent dimerization between the two nucleotide binding domains (NBD1 and NBD2) for channel opening, the thermodynamic basis for the activity potentiation by VX-770 in Trikafta remains unknown. Here, the thermoring structures and interdomain interactions of NBD2 were examined and compared with the counterparts of NBD1 with or without F508 in response to ligand binding.

View Article and Find Full Text PDF